From drug development and clinical trials to manufacturing and supply chains, meet the Teva experts with their fingers on the pulse. Click on the headlines to read more and join the discussion.
Amalia Adler-Waxman, SVP Head of Sustainability at Teva, discusses the key trends she’s keenly watching in the fast-paced area of sustainability, including integration, mandatory reporting and real-world measurable impacts
Eran Harary, Teva’s Head of Global Early Clinical Development, outlines recent trends in the sector, from the increased inclusion of patient perspectives to the growing rise of technology in research